Displaying 19 (all) recruiting clinical trials.
-
A Phase 2a Multicenter Randomized Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderate to Severe Crohn's Disease
The purpose of this study is to evaluate the safety and efficacy of using multiple investigational medicines compared to a single medicine in subjects with ...Phase
Interventional
-
A Global Randomized Open-label Multicenter Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1)
The main goal of this study is to determine the effectiveness of BJT-778 as a long-term treatment in patients with hepatitis delta virus (HDV) infection.Phase
Interventional
-
A Phase 2/3 Efficacy and Safety Study of KPL-387 Treatment in Participants with Recurrent Pericarditis
The purpose of this research study is to learn if KPL-387 is an effective and safe treatment for recurrent pericarditis. The study drug will be ...Phase
Interventional
-
A Randomized Open-label Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy
This is Phase 2/3 study testing a new medicine called iza-bren (also known as izalontamab brengitecan or BL-B01D1) for treating advanced lung cancer that ...
Phase
Interventional
-
STRIDE II: A Study of Patients with Lower Extremity Acute Limb Ischemia to Remove Thrombus with the Indigo Aspiration System
The purpose of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo Aspiration System in a patient ...Phase
Interventional
-
ICONIC-CD Protocol 77242113CRD3001: A Phase 2b/3 Randomized Double-blind Placebo-Controlled Parallel Group Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
The purpose of this research study is to help researchers understand more about the possible effectiveness and safety of icotrokinra in patients with moderately to ...Phase
Interventional
-
A Randomized Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring
CA240-0030 A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants ...Phase
Interventional
-
A Global Multicenter Randomized Double-Blind Placebo-Controlled Phase 2/3 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Participants with Stage 4 Non-Small Cell Lung Cancer (TeLuRide-008)
This Phase 2/3 study is testing whether adding EIK1001 (investigational drug) to the combination of pembrolizumab and chemotherapy is more effective in treating patients ...
Phase
Interventional
-
A Phase 2b/3 Adaptive Randomized Double-blind Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy
Currently, there are no approved drugs that are designed specifically to treat dilated cardiomyopathy (DCM). This study is being done to evaluate how well the ...Phase
Interventional
